potassium citrate 5 MEQ Extended Release Oral Tablet
1 INDICATIONS AND USAGE Potassium Citrate extended-release tablets are a citrate salt of potassium indicated for the management of: Renal tubular acidosis (RTA) with calcium stones ( 1.1 ) Hypocitraturic calcium oxalate nephrolithiasis of any etiology ( 1.2 ) Uric acid lithiasis with or without calcium stones ( 1.3 ) 1.1 Renal Tubular Acidosis (RTA) with Calcium Stones Potassium citrate is indicated for the management of renal tubular acidosis [see Clinical Studies ( 14.1 )]. 1.2 Hypocitraturic Calcium Oxalate Nephrolithiasis of any Etiology Potassium citrate is indicated for the management of hypocitraturic calcium oxalate nephrolithiasis [see Clinical Studies ( 14.2 )]. 1.3 Uric Acid Lithiasis with or without Calcium Stones Potassium citrate is indicated for the management of uric acid lithiasis with or without calcium stones [see Clinical Studies ( 14.3 )].
actavis pharma, inc.
ROUND YELLOW A67
Related Pills
potassium citrate 15 MEQ Extended Release Oral Tablet
actavis pharma, inc.
potassium citrate 10 MEQ Extended Release Oral Tablet
actavis pharma, inc.
Isotretinoin 20 MG Oral Capsule
Amneal Pharmaceuticals NY LLC
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
POTASSIUM CITRATE extended-release tablets USP, 5 mEq are tan to yellowish, speckled, uncoated, round shaped tablets, debossed with “A67” on one side and plain on the other side, supplied in bottles of 100 (NDC 0591-2682-01).
POTASSIUM CITRATE extended-release tablets USP, 10 mEq are tan to yellowish, speckled, uncoated, modified capsule shaped tablets, debossed with “A94” on one side and plain on the other side supplied in bottles of 100 (NDC 0591-2729-01).
POTASSIUM CITRATE extended-release tablets USP, 15 mEq are tan to yellowish, speckled, uncoated, modified oval shaped tablets, debossed with “A96” on one side and plain on the other side, supplied in bottles of 100 (NDC 0591-2742-01). Storage: Store at 20º to 25ºC (68º to 77ºF) [See USP Controlled Room Temperature]. Store in a tight container.
More pills like ROUND A67